Cargando…
The future role of personalized medicine in the treatment of glioblastoma multiforme
Glioblastoma multiforme (GBM) remains one of the most malignant primary central nervous system tumors. Personalized therapeutic approaches have not become standard of care for GBM, but science is fast approaching this goal. GBM’s heterogeneous genomic landscape and resistance to radiotherapy and che...
Autores principales: | Li, Jing, Di, Chunhui, Mattox, Austin K, Wu, Linda, Adamson, D Cory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513213/ https://www.ncbi.nlm.nih.gov/pubmed/23226047 http://dx.doi.org/10.2147/PGPM.S6852 |
Ejemplares similares
-
Glioblastoma Multiforme Oncogenomics and Signaling Pathways
por: Kanu, Okezie O., et al.
Publicado: (2009) -
Current and Future Novel Treatments for Glioblastoma Multiforme
por: Tyler, Betty, et al.
Publicado: (2014) -
Glioblastoma multiforme: State of the art and future therapeutics
por: Wilson, Taylor A., et al.
Publicado: (2014) -
Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)